Scientists present first genetic evidence for why placebos work

Jul 20, 2009

usually mere sugar pills designed to represent "no treatment" in a clinical treatment study. The effectiveness of the actual medication is compared with the placebo to determine if the medication works.

And yet, for some people, the works nearly as well as the medication. How well placebos work varies widely among individuals. Why that is so, and why they work at all, remains a mystery, thought to be based on some combination of biological and psychological factors.

Now, researchers at UCLA have found a new explanation: genetics. Dr. Andrew Leuchter, a professor of psychiatry at the UCLA Semel Institute for Neuroscience and Human Behavior, and colleagues report that in people suffering from major depressive disorder, or MDD, genes that influence the brain's reward pathways may modulate the response to placebos. The research appears in the August edition of the Journal of Clinical Psychopharmacology (currently available online by subscription).

Placebos are thought to act by stimulating the brain's central reward pathways by releasing a class of neurotransmitters called monoamines, specifically dopamine and norepinephrine. These are the that make us "feel good." Because the chemical signaling done by monoamines is under strong genetic control, the scientists reasoned that common genetic variations between individuals — called genetic polymorphisms — could influence the placebo response.

Researchers took blood samples from 84 people diagnosed with MDD; 32 were given medication and 52 a placebo. The researchers looked at the polymorphisms in genes that coded for two enzymes that regulate monoamine levels: catechol-O-methyltransferase (COMT) and monoamine oxidase A (MAO-A). Subjects with the highest enzyme activity within the MAO-A polymorphism had a significantly lower placebo response than those with other genotypes. With respect to COMT, those with lower enzyme activity within this polymorphism had a lower placebo response.

"Our findings suggest that patients with MDD who have specific MAO-A and COMT genotypes may be biologically advantaged or disadvantaged in mounting a placebo response, because of the activity of these two enzymes," said Leuchter, who directs the Laboratory of Brain, Behavior and Pharmacology at the UCLA Semel Institute.

"To our knowledge, this is the first study to examine the association between MAO-A and COMT polymorphisms and a response to placebo in people who suffer from major depressive disorder," he said.

Leuchter noted that this is not the sole explanation for a response to a placebo, which is likely to be caused by many factors, both biological and psychosocial. "But the data suggests that individual differences in response to placebo are significantly influenced by individual genotypes," he said.

Including the influence of genotype in the design of clinical trials could facilitate more powerful testing of future treatments, Leuchter said.

Source: University of California - Los Angeles

Explore further: US scientists make embryonic stem cells from adult skin

add to favorites email to friend print save as pdf

Related Stories

Study evaluates placebo effectiveness

Feb 01, 2006

Harvard Medical School scientists who usually use placebos to test a new treatment's effectiveness have conducted a trial testing placebos.

Genes determine whether sugar pills work

Dec 03, 2008

It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug. On the other hand, it is difficult to explain why only certain people get better from placebos. ...

The 'placebo effect' is studied

Nov 22, 2005

University of Michigan researchers say they are investigating the "placebo effect," in which pills with no medicinal value work in some people.

Recommended for you

Leeches help save woman's ear after pit bull mauling

22 hours ago

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

New pain relief targets discovered

Apr 17, 2014

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

User comments : 4

Adjust slider to filter visible comments by rank

Display comments: newest first

SincerelyTwo
not rated yet Jul 20, 2009
Have researchers recorded how long 'placebo' effects tend to last? I imagine those effects would not truly hold up to drugs since it relies on your mind being continually fooled.
mogmich
not rated yet Jul 21, 2009
The data only suggests that individual DIFFERENCES in response are influenced by the genotype.

That doesn't explain why placebos work. It can certainly not be the sole explanation, because it doesn't explain the essence of the phenomenon. Psykosocial factors are not only possible, but necessary for the reaction to be there at all.
mogmich
not rated yet Jul 21, 2009
To put it another way: A drug used for people in a coma cannot be replaced by any placebo.

You have to be awake and conscious for the effect to be there.

Consciousness means - in this connection - to be open to the influence of psykosocial factors.

Conclusion: The placebo effect as such is caused by psykosocial factors (with some differences in response for diffent genotypes).
Soylent
not rated yet Jul 21, 2009
Whenever you can cure, you can harm. Up until the late 19th century medicine still caused more deaths than it cured.

I hypothesize therefor that the placebo effect exists because it was advantageous to believe that a harmless rabbit foot or some ineffectual ranting from the village shaman was helpful; this kept you from trying an actual medical intervention(like trepanation or something).

More news stories

Treating depression in Parkinson's patients

A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's ...

Impact glass stores biodata for millions of years

(Phys.org) —Bits of plant life encapsulated in molten glass by asteroid and comet impacts millions of years ago give geologists information about climate and life forms on the ancient Earth. Scientists ...